Figure 1: Study diagram. Time schedule and major observations of the study. The SQ grass SLIT-tablet was first administered in the clinic at visit 1 (V1). Patients visited the allergist’s office subsequently about every 3 months at visit 2 (V2), visit 3 (V3), visit 4 (V4) and visit 5 (V5) for an observation period of up to 12 months. The final visit was performed after the grass pollen season (GPS). ADR=Adverse drug reaction, SLIT=Sublingual immunotherapy.
Goto home»